Table 2. irAEs and Response Rate According to Histology.
| Histology | Toxicity | Re-evaluation |
||||
|---|---|---|---|---|---|---|
| CR | PR | SE | PD | NE | ||
| Adenocarcinoma | Yes (77) | 13 | 31 | 21 | 8 | 4 |
| No (39) | 0 | 3 | 6 | 21 | 9 | |
| Squamous | Yes (27) | 2 | 12 | 9 | 4 | 0 |
| No (25) | 0 | 4 | 3 | 12 | 6 | |
CR: complete response; irAEs: immune-related adverse events; NE: not evaluated; PD: progressive disease; PR: partial response; SD: stable disease.